Cargando…
Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer
BACKGROUND AND AIM: Given their poor prognosis, patients with residual disease (RD) in the re-resection specimen of an incidental gallbladder carcinoma (IGBC) could benefit from a better selection for surgical treatment. The Gallbladder Cancer Risk Score (GBRS) has been proposed to preoperatively id...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982379/ https://www.ncbi.nlm.nih.gov/pubmed/31980034 http://dx.doi.org/10.1186/s12957-020-1794-2 |
_version_ | 1783491300605034496 |
---|---|
author | Ramos, Emilio Lluis, Nuria Llado, Laura Torras, Jaume Busquets, Juli Rafecas, Antoni Serrano, Teresa Mils, Kristel Leiva, David Fabregat, Joan |
author_facet | Ramos, Emilio Lluis, Nuria Llado, Laura Torras, Jaume Busquets, Juli Rafecas, Antoni Serrano, Teresa Mils, Kristel Leiva, David Fabregat, Joan |
author_sort | Ramos, Emilio |
collection | PubMed |
description | BACKGROUND AND AIM: Given their poor prognosis, patients with residual disease (RD) in the re-resection specimen of an incidental gallbladder carcinoma (IGBC) could benefit from a better selection for surgical treatment. The Gallbladder Cancer Risk Score (GBRS) has been proposed to preoperatively identify RD risk more precisely than T-stage alone. The aim of this study was to assess the prognostic value of RD and to validate the GBRS in a retrospective series of patients. MATERIAL AND METHODS: A prospectively collected database including 59 patients with IGBC diagnosed from December 1996 to November 2015 was retrospectively analyzed. Three locations of RD were established: local, regional, and distant. The effect of RD on overall survival (OS) was analyzed with the Kaplan-Meier method. To identify variables associated with the presence of RD, characteristics of patients with and without RD were compared using Fisher’s exact test. The relative risk of RD associated with clinical and pathologic factors was studied with a univariate logistic regression analysis. RESULTS: RD was found in 30 patients (50.8%). The presence of RD in any location was associated with worse OS (29% vs. 74.2%, p = 0.0001), even after an R0 resection (37.7% vs 74.2%, p = 0.003). There was no significant difference in survival between patients without RD and with local RD (74.2% vs 64.3%, p = 0.266), nor between patients with regional RD and distant RD (16.1% vs 20%, p = 0.411). After selecting patients in which R0 resection was achieved (n = 44), 5-year survival rate for patients without RD, local RD, and regional RD was, respectively, 74.2%, 75%, and 13.9% (p = 0.0001). The GBRS could be calculated in 25 cases (42.3%), and its usefulness to predict the presence of regional or distant RD (RDRD) was confirmed (80% in high-risk patients and 30% in intermediate risk p = 0.041). CONCLUSION: RDRD, but not local RD, represents a negative prognostic factor of OS. The GBRS was useful to preoperatively identify patients with high risk of RDRD. An R0 resection did not improve OS of patients with regional RD. |
format | Online Article Text |
id | pubmed-6982379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-69823792020-01-29 Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer Ramos, Emilio Lluis, Nuria Llado, Laura Torras, Jaume Busquets, Juli Rafecas, Antoni Serrano, Teresa Mils, Kristel Leiva, David Fabregat, Joan World J Surg Oncol Research BACKGROUND AND AIM: Given their poor prognosis, patients with residual disease (RD) in the re-resection specimen of an incidental gallbladder carcinoma (IGBC) could benefit from a better selection for surgical treatment. The Gallbladder Cancer Risk Score (GBRS) has been proposed to preoperatively identify RD risk more precisely than T-stage alone. The aim of this study was to assess the prognostic value of RD and to validate the GBRS in a retrospective series of patients. MATERIAL AND METHODS: A prospectively collected database including 59 patients with IGBC diagnosed from December 1996 to November 2015 was retrospectively analyzed. Three locations of RD were established: local, regional, and distant. The effect of RD on overall survival (OS) was analyzed with the Kaplan-Meier method. To identify variables associated with the presence of RD, characteristics of patients with and without RD were compared using Fisher’s exact test. The relative risk of RD associated with clinical and pathologic factors was studied with a univariate logistic regression analysis. RESULTS: RD was found in 30 patients (50.8%). The presence of RD in any location was associated with worse OS (29% vs. 74.2%, p = 0.0001), even after an R0 resection (37.7% vs 74.2%, p = 0.003). There was no significant difference in survival between patients without RD and with local RD (74.2% vs 64.3%, p = 0.266), nor between patients with regional RD and distant RD (16.1% vs 20%, p = 0.411). After selecting patients in which R0 resection was achieved (n = 44), 5-year survival rate for patients without RD, local RD, and regional RD was, respectively, 74.2%, 75%, and 13.9% (p = 0.0001). The GBRS could be calculated in 25 cases (42.3%), and its usefulness to predict the presence of regional or distant RD (RDRD) was confirmed (80% in high-risk patients and 30% in intermediate risk p = 0.041). CONCLUSION: RDRD, but not local RD, represents a negative prognostic factor of OS. The GBRS was useful to preoperatively identify patients with high risk of RDRD. An R0 resection did not improve OS of patients with regional RD. BioMed Central 2020-01-24 /pmc/articles/PMC6982379/ /pubmed/31980034 http://dx.doi.org/10.1186/s12957-020-1794-2 Text en © The Author(s). 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Ramos, Emilio Lluis, Nuria Llado, Laura Torras, Jaume Busquets, Juli Rafecas, Antoni Serrano, Teresa Mils, Kristel Leiva, David Fabregat, Joan Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer |
title | Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer |
title_full | Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer |
title_fullStr | Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer |
title_full_unstemmed | Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer |
title_short | Prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer |
title_sort | prognostic value and risk stratification of residual disease in patients with incidental gallbladder cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982379/ https://www.ncbi.nlm.nih.gov/pubmed/31980034 http://dx.doi.org/10.1186/s12957-020-1794-2 |
work_keys_str_mv | AT ramosemilio prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer AT lluisnuria prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer AT lladolaura prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer AT torrasjaume prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer AT busquetsjuli prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer AT rafecasantoni prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer AT serranoteresa prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer AT milskristel prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer AT leivadavid prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer AT fabregatjoan prognosticvalueandriskstratificationofresidualdiseaseinpatientswithincidentalgallbladdercancer |